IGM Biosciences, Inc.
IGMS
$1.22
$0.032.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -20.16% | -58.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.16% | -58.85% | |||
| Cost of Revenue | -49.57% | 9.96% | |||
| Gross Profit | 49.90% | -12.08% | |||
| SG&A Expenses | -90.63% | 76.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -61.44% | 23.36% | |||
| Operating Income | 61.77% | -25.37% | |||
| Income Before Tax | 40.34% | -28.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.34% | -28.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.34% | -28.24% | |||
| EBIT | 61.77% | -25.37% | |||
| EBITDA | 64.14% | -26.48% | |||
| EPS Basic | 40.53% | -27.77% | |||
| Normalized Basic EPS | 52.67% | -27.78% | |||
| EPS Diluted | 40.53% | -27.77% | |||
| Normalized Diluted EPS | 52.67% | -27.78% | |||
| Average Basic Shares Outstanding | 0.32% | 0.37% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||